Mental Health
Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study
Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study
Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.
Read More >>
Study: Certain ADHD Medications May Increase the Risk of Psychosis
Carefully Assess Bleeding Risk in Patients on Antidepressants
Monday Pharmaceutical Mystery: March 18
FDA OKs Esketamine Nasal Spray for Treatment-Resistant Depression
Extended-Release Injectable Suspension for Schizophrenia is Launched
FDA Advisory Committee Recommends Approval of Nasal Spray for Treatment-Resistant Depression
FDA Grants Approval to Market Generic Fluoxetine Tablets
View more articles >>
Clinical Trials
Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder
Internet Psychotherapy for Bipolar Disorder in Primary Care
Bipolar Research And Innovation Network - BRAIN
Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
Multimedia: Videos
Pharmacists May Not Realize They are Experiencing Fatigue in the Moment
Pharmacists May Not Realize They are Experiencing Fatigue in the Moment
Consequences of Relapses in Schizophrenia
Consequences of Relapses in Schizophrenia
Predictors of Relapse in Schizophrenia
Predictors of Relapse in Schizophrenia
Current Challenges in the Treatment of Schizophrenia
Current Challenges in the Treatment of Schizophrenia